Understanding and improving how cells communicate
Analysis and engineering of cell signaling
['FUNDING_OTHER'] · UNIVERSITY OF MINNESOTA · NIH-10830299
This study is all about figuring out how cells talk to each other, which is really important for our health, and it's designed for scientists who want to create better treatments for diseases by understanding how different signals affect cell behavior.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF MINNESOTA (nih funded) |
| Locations | 1 site (MINNEAPOLIS, UNITED STATES) |
| Trial ID | NIH-10830299 on ClinicalTrials.gov |
What this research studies
This research focuses on analyzing and engineering the ways cells signal and communicate with each other, which is crucial for human health. The team aims to develop innovative tools that will help scientists gain a deeper understanding of how different receptors interact with their ligands, especially when multiple signals are present. By overcoming challenges in studying certain important receptors, the research seeks to create new methods for mapping these interactions and potentially re-engineering receptors to change how they respond to signals. This could lead to the development of more effective therapies for various diseases.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with conditions related to cell signaling disorders or diseases that involve receptor-ligand interactions.
Not a fit: Patients with conditions unrelated to cell signaling or those who do not have any receptor-related disorders may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the creation of more targeted and effective treatments for diseases by improving our understanding of cell signaling.
How similar studies have performed: Other research has shown success in developing methods for analyzing cell signaling, indicating that this approach has potential for meaningful advancements.
Where this research is happening
MINNEAPOLIS, UNITED STATES
- UNIVERSITY OF MINNESOTA — MINNEAPOLIS, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: SARKAR, CASIM — UNIVERSITY OF MINNESOTA
- Study coordinator: SARKAR, CASIM
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.